These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
208 related articles for article (PubMed ID: 36219143)
1. Potential of food-derived bioactive peptides in alleviation and prevention of Alzheimer's disease. Zhao L; Li D; Qi X; Guan K; Chen H; Wang R; Ma Y Food Funct; 2022 Oct; 13(21):10851-10869. PubMed ID: 36219143 [TBL] [Abstract][Full Text] [Related]
2. Effects and mechanisms of natural products on Alzheimer's disease. Yang Z; Zhou DD; Huang SY; Fang AP; Li HB; Zhu HL Crit Rev Food Sci Nutr; 2023; 63(18):3168-3188. PubMed ID: 34613845 [TBL] [Abstract][Full Text] [Related]
3. Role of Withaferin A and Its Derivatives in the Management of Alzheimer's Disease: Recent Trends and Future Perspectives. Das R; Rauf A; Akhter S; Islam MN; Emran TB; Mitra S; Khan IN; Mubarak MS Molecules; 2021 Jun; 26(12):. PubMed ID: 34204308 [TBL] [Abstract][Full Text] [Related]
4. SLOH, a carbazole-based fluorophore, mitigates neuropathology and behavioral impairment in the triple-transgenic mouse model of Alzheimer's disease. Wu X; Kosaraju J; Zhou W; Tam KY Neuropharmacology; 2018 Mar; 131():351-363. PubMed ID: 29309769 [TBL] [Abstract][Full Text] [Related]
5. Screening of treatment targets for Alzheimer's disease from the molecular mechanisms of impairment by β-amyloid aggregation and tau hyperphosphorylation. Lin LF; Luo HM Neurosci Bull; 2011 Feb; 27(1):53-60. PubMed ID: 21270904 [TBL] [Abstract][Full Text] [Related]
6. Isorhynchophylline ameliorates cognitive impairment via modulating amyloid pathology, tau hyperphosphorylation and neuroinflammation: Studies in a transgenic mouse model of Alzheimer's disease. Li HQ; Ip SP; Yuan QJ; Zheng GQ; Tsim KKW; Dong TTX; Lin G; Han Y; Liu Y; Xian YF; Lin ZX Brain Behav Immun; 2019 Nov; 82():264-278. PubMed ID: 31476414 [TBL] [Abstract][Full Text] [Related]
7. Hydrocortisone Mitigates Alzheimer's-Related Cognitive Decline through Modulating Oxidative Stress and Neuroinflammation. Li J; Chen L; Liu S; Sun Y; Zhen L; Zhu Z; Wang G; Li X Cells; 2023 Sep; 12(19):. PubMed ID: 37830561 [TBL] [Abstract][Full Text] [Related]
8. Notopterygium incisum extract (NRE) rescues cognitive deficits in APP/PS1 Alzhneimer's disease mice by attenuating amyloid-beta, tau, and neuroinflammation pathology. Jiang XW; Liu WW; Wu YT; Wu Q; Lu HY; Xu ZH; Gao HY; Zhao QC J Ethnopharmacol; 2020 Mar; 249():112433. PubMed ID: 31783135 [TBL] [Abstract][Full Text] [Related]
9. Se-Methylselenocysteine Ameliorates Neuropathology and Cognitive Deficits by Attenuating Oxidative Stress and Metal Dyshomeostasis in Alzheimer Model Mice. Xie Y; Liu Q; Zheng L; Wang B; Qu X; Ni J; Zhang Y; Du X Mol Nutr Food Res; 2018 Jun; 62(12):e1800107. PubMed ID: 29688618 [TBL] [Abstract][Full Text] [Related]
10. Ebselen ameliorates β-amyloid pathology, tau pathology, and cognitive impairment in triple-transgenic Alzheimer's disease mice. Xie Y; Tan Y; Zheng Y; Du X; Liu Q J Biol Inorg Chem; 2017 Aug; 22(6):851-865. PubMed ID: 28502066 [TBL] [Abstract][Full Text] [Related]
11. Molecular Insight into the Therapeutic Promise of Flavonoids against Alzheimer's Disease. Uddin MS; Kabir MT; Niaz K; Jeandet P; Clément C; Mathew B; Rauf A; Rengasamy KRR; Sobarzo-Sánchez E; Ashraf GM; Aleya L Molecules; 2020 Mar; 25(6):. PubMed ID: 32168835 [TBL] [Abstract][Full Text] [Related]
12. Synaptic Mitochondria: An Early Target of Amyloid-β and Tau in Alzheimer's Disease. Torres AK; Jara C; Park-Kang HS; Polanco CM; Tapia D; Alarcón F; de la Peña A; Llanquinao J; Vargas-Mardones G; Indo JA; Inestrosa NC; Tapia-Rojas C J Alzheimers Dis; 2021; 84(4):1391-1414. PubMed ID: 34719499 [TBL] [Abstract][Full Text] [Related]
14. Berberine Improves Cognitive Impairment by Simultaneously Impacting Cerebral Blood Flow and β-Amyloid Accumulation in an APP/tau/PS1 Mouse Model of Alzheimer's Disease. Ye C; Liang Y; Chen Y; Xiong Y; She Y; Zhong X; Chen H; Huang M Cells; 2021 May; 10(5):. PubMed ID: 34064687 [TBL] [Abstract][Full Text] [Related]
15. The interactions of p53 with tau and Aß as potential therapeutic targets for Alzheimer's disease. Jazvinšćak Jembrek M; Slade N; Hof PR; Šimić G Prog Neurobiol; 2018 Sep; 168():104-127. PubMed ID: 29733887 [TBL] [Abstract][Full Text] [Related]
16. Amyloid-β, tau, and the cholinergic system in Alzheimer's disease: seeking direction in a tangle of clues. Majdi A; Sadigh-Eteghad S; Rahigh Aghsan S; Farajdokht F; Vatandoust SM; Namvaran A; Mahmoudi J Rev Neurosci; 2020 May; 31(4):391-413. PubMed ID: 32017704 [TBL] [Abstract][Full Text] [Related]
17. Diosmin reduces cerebral Aβ levels, tau hyperphosphorylation, neuroinflammation, and cognitive impairment in the 3xTg-AD mice. Sawmiller D; Habib A; Li S; Darlington D; Hou H; Tian J; Shytle RD; Smith A; Giunta B; Mori T; Tan J J Neuroimmunol; 2016 Oct; 299():98-106. PubMed ID: 27725131 [TBL] [Abstract][Full Text] [Related]
18. Isobavachalcone ameliorates cognitive deficits, and Aβ and tau pathologies in triple-transgenic mice with Alzheimer's disease. Zhang M; Wu Q; Zhao R; Yao X; Du X; Liu Q; Lv G; Xiao S Food Funct; 2021 Sep; 12(17):7749-7761. PubMed ID: 34269361 [TBL] [Abstract][Full Text] [Related]
19. Key Peptides and Proteins in Alzheimer's Disease. Penke B; Bogár F; Paragi G; Gera J; Fülöp L Curr Protein Pept Sci; 2019; 20(6):577-599. PubMed ID: 30605056 [TBL] [Abstract][Full Text] [Related]
20. Ginkgo biloba Extract EGb761 Attenuates Hyperhomocysteinemia-induced AD Like Tau Hyperphosphorylation and Cognitive Impairment in Rats. Zeng K; Li M; Hu J; Mahaman YAR; Bao J; Huang F; Xia Y; Liu X; Wang Q; Wang JZ; Yang Y; Liu R; Wang X Curr Alzheimer Res; 2018; 15(1):89-99. PubMed ID: 28847282 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]